|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shrestha AD, Neupane D, Vedsted P and
Kallestrup P: Cervical cancer prevalence, incidence and mortality
in low and middle income countries: A systematic review. Asian Pac
J Cancer Prev. 19:319–324. 2018.PubMed/NCBI
|
|
3
|
Pecorelli S, Zigliani L and Odicino F:
Revised FIGO staging for carcinoma of the cervix. Int J Gynecol
Obstet. 105:107–108. 2009. View Article : Google Scholar
|
|
4
|
Haie-Meder C, Morice P and Castiglione M;
ESMO Guidelines Working Group, : Cervical cancer: ESMO clinical
recommendations for diagnosis, treatment and follow-up. Ann Oncol.
(20 Suppl 4):S27–S28. 2009. View Article : Google Scholar
|
|
5
|
Tanderup K, Lindegaard JC, Kirisits C,
Haie-Meder C, Kirchheiner K, de Leeuw A, Jürgenliemk-Schulz I, Van
Limbergen E and Pötter R: Image Guided Adaptive Brachytherapy in
cervix cancer: A new paradigm changing clinical practice and
outcome. Radiother Oncol. 120:365–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fanfani F, Fagotti A, Ferrandina G,
Raspagliesi F, Ditto A, Cerrotta AM, Morganti A, Smaniotto D and
Scambia G: Neoadjuvant chemoradiation followed by radical
hysterectomy in FIGO Stage IIIB cervical cancer: Feasibility,
complications, and clinical outcome. Int J Gynecol Cancer.
19:1119–1124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Platt SL, Patel A, Humphrey PJ, Al-Booz H
and Bailey J: Completion surgery after chemoradiotherapy for
cervical cancer -is there a role? UK Cancer Centre experience of
hysterectomy post chemo-radiotherapy treatment for cervical cancer.
J Obstet Gynaecol. 39:68–73. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shim SH, Kim SN, Chae SH, Kim JE and Lee
SJ: Impact of adjuvant hysterectomy on prognosis in patients with
locally advanced cervical cancer treated with concurrent
chemoradiotherapy: A meta-analysis. J Gynecol Oncol. 29:e252018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang J, Shen K, Wang J, Yang J and Cao D:
Extrafascial hysterectomy after concurrent chemoradiotherapy in
locally advanced cervical adenocarcinoma. J Gynecol Oncol.
27:e402016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi D, Liang Z, Zhang C, Zhang H and Liu
X: The effect of surgery on the survival status of patients with
locally advanced cervical cancer after
radiotherapy/chemoradiotherapy: A meta-analysis. BMC Cancer.
18:3082018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang J, Yang J, Cao D, Shen K, Ma J and
Zhang F: Completion hysterectomy after chemoradiotherapy for
locally advanced adeno-type cervical carcinoma: Updated survival
outcomes and experience in post radiation surgery. J Gynecol Oncol.
31:e162020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Albert A, Allbright R, Lee A and
Vijayakumar S: Preoperative chemoradiation followed by hysterectomy
for cervical cancer: Patterns of care and survival in a large,
hospital database. J Gynecol Oncol. 30:e412019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; PRISMA Group, : Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. BMJ.
339:b25352009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Higgins JPT, Altman DG and Sterne JAC:
Chapter 8: Assessing risk of bias in included studies. Higgins JPT,
Churchill R, Chandler J and Cumpston MS: Cochrane Handbook for
Systematic Reviews of Interventions version 5.2.0. (updated June
2017), Cochrane, 2017. Available from. simplewww.training.cochrane.org/handbook
|
|
15
|
Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS,
Hahn S, Jang BH and Son HJ: Testing a tool for assessing the risk
of bias for nonrandomized studies showed moderate reliability and
promising validity. J Clin Epidemiol. 66:408–414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tierney JF, Stewart LA, Ghersi D, Burdett
S and Sydes MR: Practical methods for incorporating summary
time-to-event data into meta-analysis. Trials. 8:162007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wallace BC, Schmid CH, Lau J and
Trikalinos TA: Meta-Analyst: Software for meta-analysis of binary,
continuous and diagnostic data. BMC Med Res Methodol. 9:802009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li H, Pang Y and Cheng X: Surgery of
primary sites for stage IVB cervical cancer patients receiving
chemoradiotherapy: A population-based study. J Gynecol Oncol.
31:e82020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gosset M, Chargari C, Bentivegna E, Leary
A, Genestie C, Maulard A, Morice P and Gouy S: Should we cease to
perform salvage hysterectomy after chemoradiation and brachytherapy
in locally advanced cervical cancer? Anticancer Res. 39:2919–2926.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haque W, Verma V, Butler EB and Teh BS:
Utilization of hysterectomy following chemoradiation for IB2/IIA2
cervical cancer in the national cancer data base. Anticancer Res.
38:3175–3179. 2018.PubMed/NCBI
|
|
21
|
Huang XB, Zhang WW, Wu SG, Sun JY, He ZY
and Zhou J: Survival benefits with the addition of adjuvant
hysterectomy to radiochemotherapy for treatment of stage I–II
adenocarcinoma of the uterine cervix. J Surg Oncol. 118:574–580.
2018.PubMed/NCBI
|
|
22
|
Keys HM, Bundy BN, Stehman FB, Okagaki T,
Gallup DG, Burnett AF, Rotman MZ and Fowler WC Jr: Radiation
therapy with and without extrafascial hysterectomy for bulky stage
IB cervical carcinoma: A randomized trial of the Gynecologic
Oncology Group. Gynecol Oncol. 89:343–353. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Perez CA, Grigsby PW, Camel HM, Galakatos
AE, Mutch D and Lockett MA: Irradiation alone or combined with
surgery in stage IB, IIA and IIB carcinoma of uterine cervix:
Update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys.
31:703–716. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng D, Mou HP, Diao P, Li XM, Zhang CL,
Jiang J, Chen JL, Wang LS, Wang Q, Zhou GY, et al:
Chemoradiotherapy in combination with radical surgery is associated
with better outcome in cervical cancer patients. Oncotarget.
9:2866–2875. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hass P, Eggemann H, Costa SD and Ignatov
A: Adjuvant hysterectomy after radiochemotherapy for locally
advanced cervical cancer. Strahlenther Onkol. 193:1048–1055. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mazeron R, Gouy S, Chargari C, Rivin Del
Campo E, Dumas I, Mervoyer A, Genestie C, Bentivegna E, Balleyguier
C, Pautier P, et al: Post radiation hysterectomy in locally
advanced cervical cancer: Outcomes and dosimetric impact. Radiother
Oncol. 120:460–466. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fanfani F, Vizza E, Landoni F, de Iaco P,
Ferrandina G, Corrado G, Gallotta V, Gambacorta MA, Fagotti A,
Monterossi G, et al: Radical hysterectomy after chemoradiation in
FIGO stage III cervical cancer patients versus chemoradiation and
brachytherapy: Complications and 3-years survival. Eur J Surg
Oncol. 42:1519–1525. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chereau E, DE LA Hosseraye C, Ballester M,
Monnier L, Rouzier R, Touboul E and Daraï E: The role of completion
surgery after concurrent radiochemotherapy in locally advanced
stages IB2-IIB cervical cancer. Anticancer Res. 33:1661–1666.
2013.PubMed/NCBI
|
|
29
|
Wang N, Li WW, Li JP, Liu JY, Zhou YC,
Zhang Y, Hu J, Huang YH, Chen Y, Wei LC, et al: Comparison of
concurrent chemoradiotherapy followed by radical surgery and
high-dose-rate intracavitary brachytherapy: A retrospective study
of 240 patients with FIGO stage IIB cervical carcinoma. Onco
Targets Ther. 7:91–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun L, Sheng X, Jiang J, Li X, Liu N, Liu
Y, Zhang T, Li D, Zhang X and Wei P: Surgical morbidity and
oncologic results after concurrent chemoradiation therapy for
advanced cervical cancer. Int J Gynaecol Obstet. 125:111–115. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cetina L, González-Enciso A, Cantú D,
Coronel J, Pérez-Montiel D, Hinojosa J, Serrano A, Rivera L,
Poitevin A, Mota A, et al: Brachytherapy versus radical
hysterectomy after external beam chemoradiation with gemcitabine
plus cisplatin: A randomized, phase III study in IB2-IIB cervical
cancer patients. Ann Oncol. 24:2043–2047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Morice P, Rouanet P, Rey A, Romestaing P,
Houvenaeghel G, Boulanger JC, Leveque J, Cowen D, Mathevet P,
Malhaire JP, et al: Results of the GYNECO 02 study, an FNCLCC phase
III trial comparing hysterectomy with no hysterectomy in patients
with a (clinical and radiological) complete response after
chemoradiation therapy for stage IB2 or II cervical cancer.
Oncologist. 17:64–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lèguevaque P, Motton S, Delannes M,
Querleu D, Soulé-Tholy M, Tap G and Houvenaeghel G: Completion
surgery or not after concurrent chemoradiotherapy for locally
advanced cervical cancer? Eur J Obstet Gynecol Reprod Biol.
155:188–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cetina L, Garcia-Arias A, Candelaria M,
Cantú D, Rivera L, Coronel J, Bazan-Perkins B, Flores V, Gonzalez A
and Dueñas-González A: Brachytherapy versus radical hysterectomy
after external beam chemoradiation: A non-randomized matched
comparison in IB2-IIB cervical cancer patients. World J Surg Oncol.
7:192009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Darus CJ, Callahan MB, Nguyen QN, Pastore
LM, Schneider BF, Rice LW and Jazaeri AA: Chemoradiation with and
without adjuvant extrafascial hysterectomy for IB2 cervical
carcinoma. Int J Gynecol Cancer. 18:730–735. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gaffney DK, Erickson-Wittmann BA, Jhingran
A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA,
Wolfson AH, et al: ACR Appropriateness Criteria® on
advanced cervical cancer expert panel on radiation
oncology-gynecology. Int J Radiat Oncol Biol Phys. 81:609–614.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Boers A, Arts HJG, Klip H, Nijhuis ER,
Pras E, Hollema H, Wisman GB, Nijman HW, Mourits MJ, Reyners AK, et
al: Radical surgery in patients with residual disease after
(chemo)radiation for cervical cancer. Int J Gynecol Cancer.
24:1276–1285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Houvenaeghel G, Lelievre L, Buttarelli M,
Jacquemier J, Carcopino X, Viens P and Gonzague-Casabianca L:
Contribution of surgery in patients with bulky residual disease
after chemoradiation for advanced cervical carcinoma. Eur J Surg
Oncol. 33:498–503. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Azria E, Morice P, Haie-Meder C, Thoury A,
Pautier P, Lhomme C, Duvillard P and Castaigne D: Results of
hysterectomy in patients with bulky residual disease at the end of
chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg
Oncol. 12:332–337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nijhuis ER, van der Zee AGJ, in't Hout BA,
Boomgaard JJ, de Hullu JA, Pras E, Hollema H, Aalders JG, Nijman
HW, Willemse PH and Mourits MJ: Gynecologic examination and
cervical biopsies after (chemo) radiation for cervical cancer to
identify patients eligible for salvage surgery. Int J Radiat Oncol
Biol Phys. 66:699–705. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gui B, Valentini AL, Miccò M, D'Agostino
GR, Tagliaferri L, Zannoni GF, Fanfani F, Manfredi R and Bonomo L:
Cervical cancer response to neoadjuvant chemoradiotherapy: MRI
assessment compared with surgery. Acta radiol. 57:1123–1131. 2016.
View Article : Google Scholar : PubMed/NCBI
|
